195 related articles for article (PubMed ID: 6280478)
21. Effects of YS-980, an orally active converting enzyme inhibitor, on blood pressure in normotensive and hypertensive rats.
Komori T; Yamamoto K
Jpn J Pharmacol; 1981 Jun; 31(3):401-7. PubMed ID: 6273629
[TBL] [Abstract][Full Text] [Related]
22. A new potent inhibitor of converting enzyme: (2R,4R)-2-(2-hydroxyphenyl)-3-(3-mercaptopropionyl)-4-thiazolidinecarboxylic acid(SA446).
Iso T; Yamauchi H; Suda H; Nakata K; Nishimura K; Iwao J
Jpn J Pharmacol; 1981 Dec; 31(6):875-82. PubMed ID: 6174764
[TBL] [Abstract][Full Text] [Related]
23. Effects of captopril and enalapril on regional vascular resistance and reactivity in spontaneously hypertensive rats.
Richer C; Doussau MP; Giudicelli JF
Hypertension; 1983; 5(3):312-20. PubMed ID: 6188693
[TBL] [Abstract][Full Text] [Related]
24. Attenuation of pressor responses to intracerebroventricular angiotensin I by angiotensin converting enzyme inhibitors and their effects on systemic blood pressure in conscious rats.
Baum T; Becker FT; Sybertz EJ
Life Sci; 1983 Mar; 32(12):1297-303. PubMed ID: 6300578
[TBL] [Abstract][Full Text] [Related]
25. Comparison in normal volunteers of three converting enzyme inhibitors: RHC 3659, MK 421 and captopril.
Burnier M; Biollaz J; Brunner HR; Turini GA; Gavras H
Am J Cardiol; 1982 Apr; 49(6):1550-1. PubMed ID: 6280484
[No Abstract] [Full Text] [Related]
26. Effects of captopril on the development of tolerance to guanethidine.
Rankin GO; Haas GJ
Fed Proc; 1984 Apr; 43(5):1342-5. PubMed ID: 6323227
[TBL] [Abstract][Full Text] [Related]
27. Ceranapril (SQ 29,852), an orally active inhibitor of angiotensin converting enzyme (ACE).
DeForrest JM; Waldron TL; Harvey C; Scalese R; Hammerstone S; Powell JR; Karanewsky D
J Cardiovasc Pharmacol; 1990 Jul; 16(1):121-7. PubMed ID: 1696654
[TBL] [Abstract][Full Text] [Related]
28. Hypotensive effect of SA446, an angiotensin converting enzyme inhibitor, in 2-kidney, 1-clip renal hypertensive and normotensive dogs.
Nishimura K; Miyazaki M; Okunishi H; Toda N
Jpn J Pharmacol; 1987 Apr; 43(4):379-87. PubMed ID: 3039218
[TBL] [Abstract][Full Text] [Related]
29. Two inhibitors of angiotensin-converting enzyme, enalapril and captopril, increase salt appetite of rats.
Minsker DH; Bagdon WJ; Robertson RT; Bokelman DL
J Toxicol Environ Health; 1984; 14(5-6):715-22. PubMed ID: 6097696
[TBL] [Abstract][Full Text] [Related]
30. Effects of angiotensin converting enzyme inhibitor (SA-446) on regional hemodynamics in renal and spontaneously hypertensive rats.
Abe Y; Sakamoto W; Fukui K; Iwao H; Takada T; Yamamoto K
Arch Int Pharmacodyn Ther; 1988; 292():237-47. PubMed ID: 3395170
[TBL] [Abstract][Full Text] [Related]
31. Pharmacological properties of the converting enzyme inhibitor, enalapril maleate (MK-421).
Sweet CS
Fed Proc; 1983 Feb; 42(2):167-70. PubMed ID: 6295819
[TBL] [Abstract][Full Text] [Related]
32. Effects of the angiotensin converting enzyme inhibitors captopril, rentiapril, and alacepril in patients with essential and renovascular hypertension.
Ideishi M; Sasaguri M; Ikeda M; Arakawa K
Clin Ther; 1989; 11(4):441-51. PubMed ID: 2550133
[TBL] [Abstract][Full Text] [Related]
33. Acute antihypertensive synergism of angiotensin-converting enzyme inhibitors and diuretics.
Chan PS; Ronsberg MA; Cervoni P
Fed Proc; 1984 Apr; 43(5):1346-50. PubMed ID: 6200364
[TBL] [Abstract][Full Text] [Related]
34. Selective activation of the converting enzyme inhibitor MK 421 and comparison of its active diacid form with captopril in different tissues of the rat.
Unger T; Schüll B; Rascher W; Lang RE; Ganten D
Biochem Pharmacol; 1982 Oct; 31(19):3063-70. PubMed ID: 6293506
[No Abstract] [Full Text] [Related]
35. Antihypertensive action of a novel orally active angiotensin converting enzyme inhibitor altiopril calcium (MC-838) in several hypertensive models of rats: comparison with captopril.
Aono J; Koga T; Yamazaki T; Shiraki Y; Sakai K
Arch Int Pharmacodyn Ther; 1988; 292():203-22. PubMed ID: 3293542
[TBL] [Abstract][Full Text] [Related]
36. Captopril, an orally active angiotensin I converting enzyme inhibitor in the treatment of renovascular and essential hypertension.
Holtzman E; Rosenthal T; Stern N; Knecht A; Yaron A
Isr J Med Sci; 1982 May; 18(5):597-602. PubMed ID: 6284678
[TBL] [Abstract][Full Text] [Related]
37. CI-906 and CI-907: new orally active nonsulfhydryl angiotensin-converting enzyme inhibitors.
Kaplan HR; Cohen DM; Essenburg AD; Major TC; Mertz TE; Ryan MJ
Fed Proc; 1984 Apr; 43(5):1326-9. PubMed ID: 6323223
[TBL] [Abstract][Full Text] [Related]
38. Effect of acute oral administration of captopril and MK-421 on vascular angiotensin converting enzyme activity in the spontaneously hypertensive rat.
Cohen ML; Wiley KS; Kurz KD
Life Sci; 1983 Feb; 32(6):565-9. PubMed ID: 6300600
[No Abstract] [Full Text] [Related]
39. Comparisons in vitro, ex vivo, and in vivo of the actions of seven structurally diverse inhibitors of angiotensin converting enzyme (ACE).
Cushman DW; Wang FL; Fung WC; Grover GJ; Harvey CM; Scalese RJ; Mitch SL; DeForrest JM
Br J Clin Pharmacol; 1989; 28 Suppl 2(Suppl 2):115S-130S; discussion 130S-131S. PubMed ID: 2557876
[TBL] [Abstract][Full Text] [Related]
40. Antihypertensive profile of the angiotensin-converting enzyme inhibitors CI-906 and CI-907.
Ryan MJ; Boucher DM; Cohen DM; Olszewski BJ; Singer RM; Smith RD; Kaplan HR
Fed Proc; 1984 Apr; 43(5):1330-2. PubMed ID: 6323224
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
